ICD-10-CM Billable Code

M35.5

Multifocal fibrosclerosis

Clinical Classification Guidelines

Medical Intelligence & Overview

Multifocal fibrosclerosis is a rare inflammatory condition characterized by the development of fibrous tissue in multiple areas of the body. The fibrous tissue can cause organ displacement, restriction of movement, and interference with normal organ function. This condition often affects multiple organs and tissues, leading to a complex clinical presentation. While it can be challenging to diagnose and manage, understanding its features is important for recognizing symptoms and potential implications.

Causes & Symptoms

Clinical Causes: The precise cause of multifocal fibrosclerosis remains unknown. It is believed to involve an abnormal immune response, possibly triggered by infections or autoimmune mechanisms. Genetic predispositions may contribute to susceptibility, but specific genetic factors have not been well-established. Secondary causes, such as previous infections, surgeries, or trauma, may play a role in some cases. Some researchers suggest that it could be part of a broader spectrum of fibrosing disorders linked to immune dysregulation.

Key Symptoms: Swelling or palpable mass in affected areas Organ discomfort or pain, depending on the location Difficulty breathing if the lungs are involved Limited joint or organ mobility due to extensive fibrosis Enlarged lymph nodes near affected regions Skin changes, such as thickening or firmness over involved tissues Unexplained weight loss or fatigue in some cases

Diagnostic & Treatment

Diagnosis Path: Diagnosing multifocal fibrosclerosis involves a combination of clinical evaluation, imaging studies, and sometimes biopsy. Common diagnostic steps include: - Physical examination to identify palpable masses or tissue induration - Imaging techniques like ultrasound, CT scans, or MRI to visualize fibrous tissue spread - Laboratory tests, including markers for inflammation or autoimmune activity - Biopsy of affected tissue to confirm the presence of fibrous tissue and exclude other conditions Because the condition can mimic other fibrosing or inflammatory diseases, accurate diagnosis often requires multidisciplinary collaboration among specialists in rheumatology, pulmonology, and other fields.

Treatment Protocols: There is no specific cure for multifocal fibrosclerosis, and treatment focuses on managing symptoms and limiting disease progression. Common approaches include: - Use of corticosteroids or immunosuppressive agents to reduce inflammation and fibrosis - Physical therapy to maintain or improve mobility in affected areas - Surgical intervention in cases of significant organ impairment or when tissue masses cause functional blockages - Regular monitoring and supportive care tailored to the organs involved Long-term management may involve a team of healthcare providers to address evolving symptoms and prevent complications.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M35.5 a billable ICD-10 code?
Yes, M35.5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M35.5?
Clinical documentation must specify the nature of Multifocal fibrosclerosis and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

multifocal fibrosclerosis